Antifungal susceptibility testing of filamentous fungi isolated from upper respiratory tract with the Etest® method;Étude par la technique du E-test® de la sensibilité aux antifongiques de souches de champignons filamenteux isolées des voies aériennes supérieures

Journal de Mycologie Medicale

Volumn 14, Issue 2, 2004, Pages 75-77

  Kauffmann Lacroix, C ^a   Witthuhn, F ^a   Dufour, X ^a   Klossek, J M ^a   Charron, M ^a   Rodier, M H ^a  

^a POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

5 fluorocytosine; Amphotericin B; Aspergillus; E test; Filamentous fungi; Fungal rhinosinusitis; Fungus ball; Itraconazole; Voriconazole

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; FLUCYTOSINE; ITRACONAZOLE; VORICONAZOLE;

ANTIBIOTIC SENSITIVITY; ARTICLE; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; DIAGNOSTIC TEST; FUNGUS ISOLATION; HUMAN; IMMUNE DEFICIENCY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PETRIELLIDIUM BOYDII; RELAPSE; RHINOSINUSITIS; UPPER RESPIRATORY TRACT INFECTION;

ASPERGILLUS; ASPERGILLUS FLAVUS; ASPERGILLUS FUMIGATUS; FUNGI; PSEUDALLESCHERIA; PSEUDALLESCHERIA BOYDII;

EID: 3142687689     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Balajee SA, Marr KA. Conidial viability assay for rapid susceptibility testing of Aspergillus species. J Clin Microbiol 2002;40:2741-5.
2. Espinel-Ingroff A, Boyle K, Sheehan DJ. In vitro antifungal activities of voriconazole and reference agents as determined by NCCLS methods: review of the literature. Mycopathologia 2001;150:101-15.
3. Espinel-Ingroff A, Rezusta A. E-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method. J Clin Microbiol 2002:40:2101-7.
4. Gehrt A, Peter J, Pizzo PA, Walsh TJ. Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method. J Clin Microbiol 1995;33:1302-7.
5. Meletiadis J, Mouton JW, Meis JF, Bouman BA, Verweij PE. Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species. J Clin Microbiol 2002;40:2876-85.
6. Moore CB, Sayers N, Mosquera J, Slaven J, Denning DW. Antifungal drug resistance in Aspergillus. J Infect 2000;41:203-20.
7. Pfaller MA, Marco F, Messer SA, Jones RN. In vitro activity of two echinocandin derivatives, LY303366 and MK-0991 (L-743,792), against clinical isolates of Aspergillus, Fusarium, Rhizopus, and other filamentous fungi. Diagn Microbiol Infect Dis 1998;30:251-5.
8. Pfaller MA, Messer SA, Mills K, Bolmstrom A. In vitro susceptibility testing of filamentous fungi: comparison of Etest and reference microdilution methods for determining itraconazole MICs. J Clin Microbiol 2000;38:3359-61.
9. Pfaller JB, Messer SA, Hollis RJ, Diekema DJ, Pfaller MA. In vitro susceptibility testing of Aspergillus spp.: comparison of Etest and reference microdilution methods for determining voriconazole and itraconazole MICs. J Clin Microbiol 2003;41:1126-9.
10. Rex JH, Pfaller MA, Walsh TJ, et al. Antifungal susceptibility testing: practical aspects and current challenges. Clin Microbiol Rev 2001;14:643-58.
11. Szekely A, Johnson EM and Warnock DW. Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of molds. J Clin Microbiol 1999;37:1480-3.
12. Witthuhn F, Toubas D, Beguinot I, et al. Evaluation of the fungitest kit by using strains from human immunodeficiency virus-infected patients: study of azole drug susceptibility. J Clin Microbiol 1999;37:864-6.